Yongwen Luo

3.3k total citations · 1 hit paper
57 papers, 1.7k citations indexed

About

Yongwen Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yongwen Luo has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Yongwen Luo's work include Ferroptosis and cancer prognosis (11 papers), Virus-based gene therapy research (8 papers) and Animal Virus Infections Studies (7 papers). Yongwen Luo is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), Virus-based gene therapy research (8 papers) and Animal Virus Infections Studies (7 papers). Yongwen Luo collaborates with scholars based in China, United States and Netherlands. Yongwen Luo's co-authors include Jianguo He, Shaoping Weng, Gang Wang, Xinghuan Wang, Yu Xiao, Peng Zhang, Ying Yu, Zhonghua Yang, Lingao Ju and Chuanfu Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Virology.

In The Last Decade

Yongwen Luo

53 papers receiving 1.6k citations

Hit Papers

HIF1α lactylation enhances KIAA1199 transcription to prom... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongwen Luo China 24 733 488 348 285 239 57 1.7k
Patrick Lécine France 27 1.2k 1.6× 657 1.3× 204 0.6× 278 1.0× 416 1.7× 46 3.0k
Alla Musiyenko United States 20 997 1.4× 364 0.7× 298 0.9× 164 0.6× 282 1.2× 33 1.7k
Xiaofeng Wang China 26 985 1.3× 150 0.3× 333 1.0× 226 0.8× 224 0.9× 91 2.2k
Hsing-Jien Kung United States 19 1.1k 1.5× 312 0.6× 164 0.5× 401 1.4× 132 0.6× 21 2.2k
Vincenzo Ciminale Italy 35 1.3k 1.8× 1.7k 3.5× 579 1.7× 157 0.6× 263 1.1× 104 3.4k
Kui Yang China 27 935 1.3× 327 0.7× 277 0.8× 186 0.7× 102 0.4× 77 1.9k
Daisuke Yamane United States 22 1.1k 1.5× 489 1.0× 648 1.9× 96 0.3× 318 1.3× 36 2.1k
Todd P. Knutson United States 24 607 0.8× 349 0.7× 220 0.6× 133 0.5× 344 1.4× 51 1.9k
Babal K. Jha United States 29 1.7k 2.4× 904 1.9× 189 0.5× 68 0.2× 658 2.8× 88 3.1k
Steven J. Werden United States 19 813 1.1× 345 0.7× 296 0.9× 104 0.4× 74 0.3× 23 1.6k

Countries citing papers authored by Yongwen Luo

Since Specialization
Citations

This map shows the geographic impact of Yongwen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwen Luo more than expected).

Fields of papers citing papers by Yongwen Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwen Luo. The network helps show where Yongwen Luo may publish in the future.

Co-authorship network of co-authors of Yongwen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwen Luo. A scholar is included among the top collaborators of Yongwen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwen Luo. Yongwen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhilong, Xiaoyu Tang, Yongwen Luo, et al.. (2025). Evaluating the learning curve for flexible ureteroscopic thulium fiber laser lithotripsy using CUSUM analysis. International Journal of Surgery. 111(3). 2430–2438.
2.
Liu, Yiting, Guoyong Li, Jingyan Zhang, et al.. (2025). Chebulinic acid from Chebulae fructus alleviates influenza virus-induced acute lung injury by inhibiting IDO1-Kyn axis activation. Phytomedicine. 148. 157362–157362.
3.
Liu, Jianmin, Yongwen Luo, Siming Chen, et al.. (2024). Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT. Advanced Science. 11(45). e2403995–e2403995. 11 indexed citations
4.
Liu, Tao, Gang Wang, Rui Cao, et al.. (2023). Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation. Cell Death and Disease. 14(11). 774–774. 14 indexed citations
5.
Tang, Jianing, et al.. (2022). USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Cell Death and Disease. 13(4). 326–326. 19 indexed citations
6.
Luo, Yongwen, Zhiwen He, Wei Liu, et al.. (2022). DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis. Oxidative Medicine and Cellular Longevity. 2022(1). 23 indexed citations
7.
Tang, Jianing, Yongwen Luo, Guo Long, & Ledu Zhou. (2021). MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Cell Death and Disease. 12(10). 937–937. 23 indexed citations
8.
Luo, Jun, Yue Zhang, Yang Wang, et al.. (2021). Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication. Virologica Sinica. 36(4). 721–729. 12 indexed citations
9.
Wang, Jie, et al.. (2020). A descriptive study of random forest algorithm for predicting COVID-19 patients outcome. PeerJ. 8. e9945–e9945. 29 indexed citations
10.
Xie, Junjie, Yu Zhong, Rong Chen, et al.. (2020). Serum long non‐coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma. FEBS Open Bio. 10(9). 1802–1809. 14 indexed citations
11.
Liu, Wei, Yongwen Luo, Gang Wang, et al.. (2020). Conditional survival after surgery for patients with penile cancer. Andrology. 8(6). 1744–1752. 7 indexed citations
13.
Tang, Jianing, Yongwen Luo, Zelin Tian, et al.. (2020). TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Neoplasia. 22(9). 343–351. 41 indexed citations
14.
Zhou, Qiang, Song Chen, Mengxin Lü, et al.. (2019). EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer. International Journal of Biological Sciences. 15(10). 2139–2155. 50 indexed citations
15.
Lü, Mengxin, Qiangqiang Ge, Gang Wang, et al.. (2018). CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α. Cell Death and Disease. 9(10). 1046–1046. 44 indexed citations
16.
Liu, Wenjun, Jingjing Pei, Xiaoying Dong, et al.. (2013). Molecular phylogenetic and positive selection analysis of Japanese encephalitis virus strains isolated from pigs in China. Virus Research. 178(2). 547–552. 14 indexed citations
17.
Luo, Yongwen, Ying Zhang, Xianfeng Yang, et al.. (2012). Complete Genome Sequence of a Highly Virulent Rabies Virus Isolated from a Rabid Pig in South China. Journal of Virology. 86(22). 12454–12455. 16 indexed citations
18.
Zhang, Chaozheng, Zhi-Xin Yin, Wei He, et al.. (2009). Cloning of IRAK1 and its upregulation in symptomatic mandarin fish infected with ISKNV. Biochemical and Biophysical Research Communications. 383(3). 298–302. 25 indexed citations
19.
Zhao, Zhiying, Zhi-Xin Yin, Xiaopeng Xu, et al.. (2008). A Novel C-Type Lectin from the Shrimp Litopenaeus vannamei Possesses Anti-White Spot Syndrome Virus Activity. Journal of Virology. 83(1). 347–356. 191 indexed citations
20.
Wang, Qing, Yongwen Luo, Junfeng Xie, et al.. (2008). Identification of two novel membrane proteins from the Tiger frog virus (TFV). Virus Research. 136(1-2). 35–42. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026